Detalles de la búsqueda
1.
A quantitative assessment of the consistency of projections from five mathematical models of the HIV epidemic in South Africa: a model comparison study.
BMC Public Health
; 23(1): 2119, 2023 10 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-37891514
2.
Potential Impact and Cost-Effectiveness of Condomless-Sex-Concentrated PrEP in KwaZulu-Natal Accounting for Drug Resistance.
J Infect Dis
; 223(8): 1345-1355, 2021 04 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-31851759
3.
Clinical Outcomes of 2-Drug Regimens vs 3-Drug Regimens in Antiretroviral Treatment-Experienced People Living With Human Immunodeficiency Virus.
Clin Infect Dis
; 73(7): e2323-e2333, 2021 10 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33354721
4.
Sustainable HIV treatment in Africa through viral-load-informed differentiated care.
Nature
; 528(7580): S68-76, 2015 Dec 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-26633768
5.
Identifying Key Drivers of the Impact of an HIV Cure Intervention in Sub-Saharan Africa.
J Infect Dis
; 214(1): 73-9, 2016 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27034345
6.
Associations between change in BMI and the risk of hypertension and dyslipidaemia in people receiving integrase strand-transfer inhibitors, tenofovir alafenamide, or both compared with other contemporary antiretroviral regimens: a multicentre, prospective observational study from the RESPOND consortium cohorts.
Lancet HIV
; 11(5): e321-e332, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38621392
7.
Potential cost-effectiveness of community availability of tenofovir, lamivudine, and dolutegravir for HIV prevention and treatment in east, central, southern, and west Africa: a modelling analysis.
Lancet Glob Health
; 11(10): e1648-e1657, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37734807
8.
Cost-effectiveness of voluntary medical male circumcision for HIV prevention across sub-Saharan Africa: results from five independent models.
Lancet Glob Health
; 11(2): e244-e255, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36563699
9.
Predicted effects of the introduction of long-acting injectable cabotegravir pre-exposure prophylaxis in sub-Saharan Africa: a modelling study.
Lancet HIV
; 10(4): e254-e265, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36642087
10.
Recent abacavir use and incident cardiovascular disease in contemporary-treated people with HIV.
AIDS
; 37(3): 467-475, 2023 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36001525
11.
Trends in Cancer Incidence in Different Antiretroviral Treatment-Eras amongst People with HIV.
Cancers (Basel)
; 15(14)2023 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37509301
12.
Transmission reduction, health benefits, and upper-bound costs of interventions to improve retention on antiretroviral therapy: a combined analysis of three mathematical models.
Lancet Glob Health
; 10(9): e1298-e1306, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35961353
13.
Estimation of HIV incidence from analysis of HIV prevalence patterns among female sex workers in Zimbabwe.
AIDS
; 36(8): 1141-1150, 2022 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35170527
14.
Integrase Strand Transfer Inhibitor Use and Cancer Incidence in a Large Cohort Setting.
Open Forum Infect Dis
; 9(3): ofac029, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-35198646
15.
Associations between integrase strand-transfer inhibitors and cardiovascular disease in people living with HIV: a multicentre prospective study from the RESPOND cohort consortium.
Lancet HIV
; 9(7): e474-e485, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35688166
16.
Cost-effectiveness of easy-access, risk-informed oral pre-exposure prophylaxis in HIV epidemics in sub-Saharan Africa: a modelling study.
Lancet HIV
; 9(5): e353-e362, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35489378
17.
The risks and benefits of providing HIV services during the COVID-19 pandemic.
PLoS One
; 16(12): e0260820, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34941876
18.
The potential role of long-acting injectable cabotegravir-rilpivirine in the treatment of HIV in sub-Saharan Africa: a modelling analysis.
Lancet Glob Health
; 9(5): e620-e627, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33770513
19.
Contemporary antiretrovirals and body-mass index: a prospective study of the RESPOND cohort consortium.
Lancet HIV
; 8(11): e711-e722, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34555326
20.
Potential effects of disruption to HIV programmes in sub-Saharan Africa caused by COVID-19: results from multiple mathematical models.
Lancet HIV
; 7(9): e629-e640, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32771089